Posted on Leave a comment

Metastatic Colorectal Cancer (mCRC) Market Anticipating Remarkable Growth by 2032, Insights by DelveInsight | Merck, Alexion, GlaxoSmithKline, EpicentRx, Pfizer, Eli Lilly, Taiho Oncology, Amgen

Delveinsight Business Research LLP In 2021, the Metastatic Colorectal Cancer (mCRC) Market size in the 7MM was USD 12,613.9 million, which is expected to rise during the study period (2019-2032). As per DelveInsight, the Metastatic Colorectal Cancer Market is anticipated to evolve immensely in the coming years owing to the rise in the number of […]

Posted on Leave a comment

SMX PLC’s 51% Stake In trueGold Consortium Supports A Share Price 10X Its Current ($SMX)

SMX PLC (NASDAQ: SMX) made an announcement in October that appears to be traveling under investor’s radar. For those looking for undervalued investment opportunities, it should be bright on their screens. Why? Because SMX is making deals and acquiring assets that make it a much larger and more valuable company, with tangible assets value alone […]

Posted on Leave a comment

“Unleashing a Medical Revolution: Transformative Breakthroughs in Diagnosis and Treatment” VTAK, ALDX, MNPR, INBS, SIEN

Catheter Precision (NYSEAMERICAN: VTAK): The United States-based medical device company has developed the VIVO™ 3D Mapping System. The non-invasive system helps physicians identify the origin of ventricular arrhythmias prior to procedures. It also received marketing clearance from the United States FDA and boasts the CE mark. It had been designed by Catheter Precision to provide a […]

Posted on Leave a comment

Paroxysmal Nocturnal Hemoglobinuria Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Roche, Biocad, Apellis, Regeneron, MorphoSys

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Paroxysmal Nocturnal Hemoglobinuria therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Alarum Technologies’ Growth Pace Shifts To High Gear, Shares Surge 39% YTD As Nine-Month Revenues Exceed Entire 2022 Total ($ALAR)

Alarum Technologies (NASDAQ: ALAR) (TASE: ALAR) growth pace is shifting from hyper to warp. And that’s no exaggeration. In fact, in ALAR’s case, they are putting an exclamation point on that assessment, posting preliminary YTD revenues of $19.3 million, a total that, when formally published, will eclipse the income generated in all of 2022. Rightfully, […]

Posted on Leave a comment

Metatron ($MRNJ) Revolutionizes Stock Analysis with AI-Powered Stock Trendz

AI is reshaping the global economic landscape. Analysts project that by 2030, AI innovations could contribute over $15 trillion to the worldwide economy, surpassing the combined current economies of China and India. This immense potential has ignited a buzz on Wall Street. Numerous AI-focused stocks have thrived recently, delivering impressive investment yields. However, as with […]

Posted on Leave a comment

Collective Audience, Inc. Stock Presents A Compelling Value For Investors Wanting Exposure To Massive Adtech Sector ($CAUD)

At its current price, Collective Audience, Inc. (NASDAQ: CAUD) stock presents what can be best described as a bargain basement investment opportunity at current levels. And that’s no exaggeration, especially after CAUD announced completing the business combination involving DLQ, Inc., a former subsidiary of Logiq, Inc (OTCQX: LGIQ), and Abri SPAC I, Inc., a special purpose acquisition company […]

Posted on Leave a comment

Delhi NCR’s Largest Battery Storage System To Reduce Carbon Emissions

Su-vastika, a pioneer in green energy solutions, proudly announces its latest milestone – the installation of its largest battery energy storage system in Mahipalpur, New Delhi. This groundbreaking project signifies a significant leap towards a more sustainable and eco-friendly future by replacing a 300 kVA diesel generator, known for its inefficiency and pollution, with a […]

Posted on Leave a comment

Respiratory Syncytial Virus (RSV) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Enanta, ReViral, Pfizer, Sanofi, BioComo

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Respiratory Syncytial Virus therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Geographic Atrophy Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ionis, IVERIC bio, Apellis, Annexon, Novartis, Astellas

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 23+ key pharma and biotech companies are working on 25+ pipeline drugs in the Geographic Atrophy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]